Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06025058Not ApplicableCompleted

Neopep-S-based EasyDew MD Regen Cream for Radiotherapy Subject After Breast Tumor Resection

Role: lead

NCT05994781Not ApplicableCompleted

A Prospective Researcher-led Clinical Study of Neopep-S-based EasyDew MD Regen Cream

Role: lead

NCT05982535Not ApplicableCompleted

Neopep-S Ingredient Easy Dew MD Regen Cream

Role: lead

NCT05982509Not ApplicableCompleted

Clinical Trial to Assess the Efficacy and Safety of EASYDEW MD REGEN Cream Containing Neopop-S.

Role: lead

All 4 trials loaded